← Back to Search

Procedure

EndoSound Vision System for Gastrointestinal Tumor

N/A

Recruiting

Led By Ji Young Bang, MD MPH

Research Sponsored by Orlando Health, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 7 days

Awards & highlights

Study Summary

"This trial is comparing the standard echoendoscope with a new device called the EndoSound Visual System to see which one is better at evaluating lesions in the gastrointestinal tract."

Who is the study for?

This trial is for individuals with conditions like pancreatic cancer, bile duct cancer, and various gastrointestinal tumors. Participants should be suitable candidates for an endoscopic ultrasound examination.Check my eligibility

What is being tested?

The study is testing a new device called the EndoSound Visual System against the standard echoendoscope to see which is better at evaluating lesions in the gastrointestinal tract.See study design

What are the potential side effects?

Potential side effects may include discomfort, minor bleeding or bruising from the procedure site, infection risk, and rare cases of more serious complications related to endoscopy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 7 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~7 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Rate of successful completion of the requisite EUS examination

Secondary outcome measures

Diagnostic accuracy of procured specimen

Diagnostic adequacy of procured specimen in cell block

Diagnostic adequacy of procured specimen on onsite evaluation

+6 more

Trial Design

2Treatment groups

Active Control

Group I: EndoSound Vision SystemActive Control1 Intervention

EndoSound Vision System will be used and EUS examination will be performed per standard of care.

Group II: Standard echoendoscopeActive Control1 Intervention

Standard echoendoscope will be used and EUS examination will be performed per standard of care.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Orlando Health, Inc.Lead Sponsor

28 Previous Clinical Trials

12,603 Total Patients Enrolled

Ji Young Bang, MD MPHPrincipal InvestigatorOrlando Health, Digestive Health Institute

5 Previous Clinical Trials

1,803 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment for this study currently available to prospective participants?

"As per the details available on clinicaltrials.gov, this research endeavor is actively seeking suitable participants. The trial was first listed on March 25th, 2024 and underwent its latest update on the same day."

Answered by AI

What is the current number of participants eligible for enrollment in this clinical research study?

"Affirmative. The information available on clinicaltrials.gov indicates that this study is currently enrolling subjects. It was initially posted on March 25, 2024, with the most recent update also done on the same day. Approximately 140 participants are sought from a single site for this trial."

Answered by AI

Are there any age restrictions for potential participants in this clinical trial, specifically with regards to individuals over the age of 35?

"Individuals aged between 18 and 100 years are eligible to participate in this clinical research project. Notably, there are eight ongoing trials focusing on pediatric patients under the age of 18, while a substantial number of 802 trials cater specifically to individuals over the age of 65."

Answered by AI

Am I eligible to be a part of this medical study?

"Individuals diagnosed with pancreatic carcinoma and aged between 18 to 100 years old are eligible for enrollment in this trial, which has a capacity of accepting up to 140 participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope

2024. "EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06340620.

All > Vision > Tampa